- Home
- CPZ vs HRTX Comparison
CPZ vs HRTX Comparison
Compare CPZ & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPZ
- HRTX
- Stock Information
- Founded
- CPZ 2019
- HRTX 1983
- Country
- CPZ United States
- HRTX United States
- Employees
- CPZ N/A
- HRTX N/A
- Industry
- CPZ Trusts Except Educational Religious and Charitable
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- CPZ Finance
- HRTX Health Care
- Exchange
- CPZ Nasdaq
- HRTX Nasdaq
- Market Cap
- CPZ 328.1M
- HRTX 276.1M
- IPO Year
- CPZ N/A
- HRTX 1987
- Fundamental
- Price
- CPZ $16.72
- HRTX $1.35
- Analyst Decision
- CPZ
- HRTX Strong Buy
- Analyst Count
- CPZ 0
- HRTX 2
- Target Price
- CPZ N/A
- HRTX $4.50
- AVG Volume (30 Days)
- CPZ 63.0K
- HRTX 2.6M
- Earning Date
- CPZ 01-01-0001
- HRTX 08-08-2025
- Dividend Yield
- CPZ 11.07%
- HRTX N/A
- EPS Growth
- CPZ N/A
- HRTX N/A
- EPS
- CPZ N/A
- HRTX N/A
- Revenue
- CPZ N/A
- HRTX $149,694,000.00
- Revenue This Year
- CPZ N/A
- HRTX $10.62
- Revenue Next Year
- CPZ N/A
- HRTX $12.99
- P/E Ratio
- CPZ N/A
- HRTX N/A
- Revenue Growth
- CPZ N/A
- HRTX 9.78
- 52 Week Low
- CPZ $13.17
- HRTX $1.04
- 52 Week High
- CPZ $16.11
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- CPZ 60.18
- HRTX 36.48
- Support Level
- CPZ $16.50
- HRTX $1.33
- Resistance Level
- CPZ $16.70
- HRTX $1.43
- Average True Range (ATR)
- CPZ 0.18
- HRTX 0.07
- MACD
- CPZ 0.00
- HRTX 0.02
- Stochastic Oscillator
- CPZ 81.40
- HRTX 45.45
About CPZ Calamos Long/Short Equity & Dynamic Income Trust
Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.